BACKGROUND: Bone morphogenetic proteins (BMPs) transmit signals via the intracellular protein Smad1, which is phosphorylated by ligand bound receptors, translocates to the nucleus, and functions to activate BMP target genes. Recently, a subclass of Smad proteins has been shown to inhibit, rather than transduce, BMP signalling, either by binding to the intracellular domain of BMP receptors, thereby preventing phosphorylation-mediated activation of Smad1, or by binding directly to Smad1, thereby inhibiting its ability to activate gene transcription. RESULTS: We have identified a Xenopus Smad (Smad6) that is 52% identical to mammalian Smad6, an inhibitory Smad. The spatial pattern of expression of Smad6 changes dynamically during embryogenesis and is similar to that of BMP-4 at the tailbud stage. Overexpression of Smad6 in Xenopus embryos phenocopies the effect of blocking BMP-4 signalling, leading to dorsalization of mesoderm and neuralization of ectoderm. Xenopus Smad6 completely blocks the activity of exogenous BMP-4, and, unlike human Smad6, partially blocks the activity of activin, in a mesoderm induction assay. We also find that Smad6 protein accumulates at the membrane in some cells but is partially or completely restricted to nuclei of most overexpressing cells. CONCLUSIONS: We have identified an inhibitory Xenopus Smad, Smad6, that functions as an intracellular antagonist of activin and BMP-4 signalling. Our finding that Smad6 protein is partially or completely restricted to nuclei of most overexpressing cells suggests that it may employ a novel or additional mechanism of action to antagonize TGF-beta family signalling other than that reported for other inhibitory Smads.

This article has been cited by other articles:

				H. Wan, F. Luo, S. E. Wert, L. Zhang, Y. Xu, M. Ikegami, Y. Maeda, S. M. Bell, and J. A. Whitsett Kruppel-like factor 5 is required for perinatal lung morphogenesis and function Development, August 1, 2008; 135(15): 2563 - 2572. [Abstract] [Full Text] [PDF]

				D. C. Wan, J. H. Pomerantz, L. J. Brunet, J.-B. Kim, Y.-F. Chou, B. M. Wu, R. Harland, H. M. Blau, and M. T. Longaker Noggin Suppression Enhances in Vitro Osteogenesis and Accelerates in Vivo Bone Formation J. Biol. Chem., September 7, 2007; 282(36): 26450 - 26459. [Abstract] [Full Text] [PDF]

				S. Zhang, T. Fei, L. Zhang, R. Zhang, F. Chen, Y. Ning, Y. Han, X.-H. Feng, A. Meng, and Y.-G. Chen Smad7 Antagonizes Transforming Growth Factor {beta} Signaling in the Nucleus by Interfering with Functional Smad-DNA Complex Formation Mol. Cell. Biol., June 15, 2007; 27(12): 4488 - 4499. [Abstract] [Full Text] [PDF]

				S. Sangadala, S. D. Boden, M. Viggeswarapu, Y. Liu, and L. Titus LIM Mineralization Protein-1 Potentiates Bone Morphogenetic Protein Responsiveness via a Novel Interaction with Smurf1 Resulting in Decreased Ubiquitination of Smads J. Biol. Chem., June 23, 2006; 281(25): 17212 - 17219. [Abstract] [Full Text] [PDF]

				M. Ku, S. Howard, W. Ni, G. Lagna, and A. Hata OAZ Regulates Bone Morphogenetic Protein Signaling through Smad6 Activation J. Biol. Chem., February 24, 2006; 281(8): 5277 - 5287. [Abstract] [Full Text] [PDF]

				T. Oren, I. Torregroza, and T. Evans An Oct-1 binding site mediates activation of the gata2 promoter by BMP signaling Nucleic Acids Res., August 1, 2005; 33(13): 4357 - 4367. [Abstract] [Full Text] [PDF]

				D. T. Berg, L. J. Myers, M. A. Richardson, G. Sandusky, and B. W. Grinnell Smad6s Regulates Plasminogen Activator Inhibitor-1 through a Protein Kinase C-{beta}-dependent Up-regulation of Transforming Growth Factor-{beta} J. Biol. Chem., April 15, 2005; 280(15): 14943 - 14947. [Abstract] [Full Text] [PDF]

				C. Linker and C. D. Stern Neural induction requires BMP inhibition only as a late step, and involves signals other than FGF and Wnt antagonists Development, November 15, 2004; 131(22): 5671 - 5681. [Abstract] [Full Text] [PDF]

				M. Schmerer and T. Evans Primitive erythropoiesis is regulated by Smad-dependent signaling in postgastrulation mesoderm Blood, November 1, 2003; 102(9): 3196 - 3205. [Abstract] [Full Text] [PDF]

				S.-I. Osada, S.-y. Ohmori, and M. Taira XMAN1, an inner nuclear membrane protein, antagonizes BMP signaling by interacting with Smad1 in Xenopus embryos Development, May 1, 2003; 130(9): 1783 - 1794. [Abstract] [Full Text] [PDF]

				G. Sandusky, D. T. Berg, M. A. Richardson, L. Myers, and B. W. Grinnell Modulation of Thrombomodulin-dependent Activation of Human Protein C through Differential Expression of Endothelial Smads J. Biol. Chem., December 13, 2002; 277(51): 49815 - 49819. [Abstract] [Full Text] [PDF]

				S. Bai and X. Cao A Nuclear Antagonistic Mechanism of Inhibitory Smads in Transforming Growth Factor-beta Signaling J. Biol. Chem., February 1, 2002; 277(6): 4176 - 4182. [Abstract] [Full Text] [PDF]

				I. Munoz-Sanjuan, E. Bell, C. R. Altmann, A. Vonica, and A. H. Brivanlou Gene profiling during neural induction in Xenopus laevis: regulation of BMP signaling by post-transcriptional mechanisms and TAB3, a novel TAK1-binding protein Development, January 12, 2002; 129(23): 5529 - 5540. [Abstract] [Full Text] [PDF]

				A. Hanyu, Y. Ishidou, T. Ebisawa, T. Shimanuki, T. Imamura, and K. Miyazono The N domain of Smad7 is essential for specific inhibition of transforming growth factor-{beta} signaling J. Cell Biol., December 10, 2001; 155(6): 1017 - 1028. [Abstract] [Full Text] [PDF]

				C. A. Muro-Cacho, K. Rosario-Ortiz, S. Livingston, and T. Munoz-Antonia Defective Transforming Growth Factor {beta} Signaling Pathway in Head and Neck Squamous Cell Carcinoma as Evidenced by the Lack of Expression of Activated Smad2 Clin. Cancer Res., June 1, 2001; 7(6): 1618 - 1626. [Abstract] [Full Text] [PDF]

				S. Bai, X. Shi, X. Yang, and X. Cao Smad6 as a Transcriptional Corepressor J. Biol. Chem., March 17, 2000; 275(12): 8267 - 8270. [Abstract] [Full Text] [PDF]

				E. PIEK, C.-H. HELDIN, and P. TEN DIJKE Specificity, diversity, and regulation in TGF-{beta} superfamily signaling FASEB J, December 1, 1999; 13(15): 2105 - 2124. [Abstract] [Full Text]

				M. Fujii, K. Takeda, T. Imamura, H. Aoki, T. K. Sampath, S. Enomoto, M. Kawabata, M. Kato, H. Ichijo, and K. Miyazono Roles of Bone Morphogenetic Protein Type I Receptors and Smad Proteins in Osteoblast and Chondroblast Differentiation Mol. Biol. Cell, November 1, 1999; 10(11): 3801 - 3813. [Abstract] [Full Text]

				A. Ishisaki, K. Yamato, S. Hashimoto, A. Nakao, K. Tamaki, K. Nonaka, P. ten Dijke, H. Sugino, and T. Nishihara Differential Inhibition of Smad6 and Smad7 on Bone Morphogenetic Protein- and Activin-mediated Growth Arrest and Apoptosis in B Cells J. Biol. Chem., May 7, 1999; 274(19): 13637 - 13642. [Abstract] [Full Text] [PDF]

				S. Souchelnytskyi, T. Nakayama, A. Nakao, A. Moren, C.-H. Heldin, J. L. Christian, and P. ten Dijke Physical and Functional Interaction of Murine and Xenopus Smad7 with Bone Morphogenetic Protein Receptors and Transforming Growth Factor-beta Receptors J. Biol. Chem., September 25, 1998; 273(39): 25364 - 25370. [Abstract] [Full Text] [PDF]

				J. Zhao, W. Shi, H. Chen, and D. Warburton Smad7 and Smad6 Differentially Modulate Transforming Growth Factor beta -induced Inhibition of Embryonic Lung Morphogenesis J. Biol. Chem., July 28, 2000; 275(31): 23992 - 23997. [Abstract] [Full Text] [PDF]